Risk of relapse in childhood acute lymphoblastic leukemia is related to RBC methotrexate and mercaptopurine metabolites during maintenance chemotherapy. Nordic Society for Pediatric Hematology and Oncology.
K. Schmiegelow, H. Schrøder, G. Gustafsson, J. Kristinsson +3 more

